Activist Investor Ananym Urges Bio-Techne to Consider Selling
Activist investor Ananym Capital Management has built a stake in Bio-Techne Corp. and is pushing the board to conduct a strategic review that would include a potential sale.
By Mengqi Sun · Bloomberg Markets
Activist investor Ananym Capital Management has built a stake in Bio-Techne Corp. and is pushing the board to conduct a strategic review that would include a potential sale.